anti-FSHR CAR T-cell therapy
- Generic Name
- anti-FSHR CAR T-cell therapy
Infusion of Autologous T Cells Engineered to Target FSH Receptor in Recurrent Ovarian Cancer
Phase 1
Recruiting
- Conditions
- Ovarian Cancer
- Interventions
- First Posted Date
- 2022-04-07
- Last Posted Date
- 2025-05-21
- Target Recruit Count
- 10
- Registration Number
- NCT05316129
- Locations
- 🇺🇸
Moffitt Cancer Center, Tampa, Florida, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath